SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-22-013780
Filing Date
2022-04-08
Accepted
2022-04-08 16:06:19
Documents
6
Effectiveness Date
2022-04-08

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10036140_s8.htm S-8 93398
2 EXHIBIT 5.1 brhc10036140_ex5-1.htm EX-5.1 23031
3 EXHIBIT 23.1 brhc10036140_ex23-1.htm EX-23.1 2618
4 FILING FEES TABLE brhc10036140_ex107.htm EX-FILING FEES 23266
5 image00002.jpg GRAPHIC 6112
6 image00003.jpg GRAPHIC 4018
  Complete submission text file 0001140361-22-013780.txt   157545
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-264204 | Film No.: 22817019
SIC: 2834 Pharmaceutical Preparations